Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;9(9):921-32.
doi: 10.1016/S1474-4422(10)70168-X.

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis

Affiliations

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis

Axel Petzold et al. Lancet Neurol. 2010 Sep.

Erratum in

  • Lancet Neurol. 2010 Nov;9(11):1045

Abstract

Optical coherence tomography (OCT) is a new method that could aid analysis of neurodegeneration in multiple sclerosis (MS) by capturing thinning of the retinal nerve fibre layer (RNFL). Meta-analyses of data for time domain OCT show RNFL thinning of 20.38 microm (95% CI 17.91-22.86, n=2063, p<0.0001) after optic neuritis in MS, and of 7.08 microm (5.52-8.65, n=3154, p<0.0001) in MS without optic neuritis. The estimated RNFL thinning in patients with MS is greater than the extent expected in normal ageing, probably because of retrograde trans-synaptic degeneration and progressive loss of retinal ganglion cells, in addition to the more pronounced thinning caused by optic neuritis if present. RNFL thickness correlates with visual and neurological functioning as well as with paraclinical data. Developments that could improve understanding of the relation between structure and function in MS pathophysiology include spectral or Fourier domain OCT technology, polarisation-sensitive OCT, fluorescence labelling, structural assessment of action-potential propagation, and segmentation algorithms allowing quantitative assessment of retinal layers.

PubMed Disclaimer

Similar articles

Cited by

  • Imaging the visual pathway in neuromyelitis optica.
    Pfueller CF, Paul F. Pfueller CF, et al. Mult Scler Int. 2011;2011:869814. doi: 10.1155/2011/869814. Epub 2011 Mar 16. Mult Scler Int. 2011. PMID: 22135746 Free PMC article.
  • Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.
    Ontaneda D, Fox RJ, Chataway J. Ontaneda D, et al. Lancet Neurol. 2015 Feb;14(2):208-23. doi: 10.1016/S1474-4422(14)70264-9. Lancet Neurol. 2015. PMID: 25772899 Free PMC article. Review.
  • The OSCAR-IB consensus criteria for retinal OCT quality assessment.
    Tewarie P, Balk L, Costello F, Green A, Martin R, Schippling S, Petzold A. Tewarie P, et al. PLoS One. 2012;7(4):e34823. doi: 10.1371/journal.pone.0034823. Epub 2012 Apr 19. PLoS One. 2012. PMID: 22536333 Free PMC article.
  • Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS.
    Brandt AU, Zimmermann H, Kaufhold F, Promesberger J, Schippling S, Finis D, Aktas O, Geis C, Ringelstein M, Ringelstein EB, Hartung HP, Paul F, Kleffner I, Dörr J. Brandt AU, et al. PLoS One. 2012;7(6):e38741. doi: 10.1371/journal.pone.0038741. Epub 2012 Jun 11. PLoS One. 2012. PMID: 22701702 Free PMC article.
  • Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
    Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators. Fox RJ, et al. N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583. N Engl J Med. 2018. PMID: 30157388 Free PMC article. Clinical Trial.

Publication types